CO6721021A2 - Pharmaceutical controlled-release tablet for oral administration - Google Patents

Pharmaceutical controlled-release tablet for oral administration

Info

Publication number
CO6721021A2
CO6721021A2 CO13145004A CO13145004A CO6721021A2 CO 6721021 A2 CO6721021 A2 CO 6721021A2 CO 13145004 A CO13145004 A CO 13145004A CO 13145004 A CO13145004 A CO 13145004A CO 6721021 A2 CO6721021 A2 CO 6721021A2
Authority
CO
Colombia
Prior art keywords
oral administration
release tablet
pharmaceutical controlled
active substance
tablets
Prior art date
Application number
CO13145004A
Other languages
Spanish (es)
Inventor
Paniagua Maria Angelica Arzola
Arroyo Hector Senosiain
Hernandez Gustavo Barranco
Original Assignee
Senosiain S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46245166&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6721021(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Senosiain S A De C V Lab filed Critical Senosiain S A De C V Lab
Publication of CO6721021A2 publication Critical patent/CO6721021A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a composiciones farmacéuticas en forma de comprimidos para administración oral, que contienen principio activo y excipientes farmacéuticamente aceptables. Los comprimidos se caracterizan porque una parte del principio activo se libera en forma inmediata y otra parte del principio activo se encuentra en un sistema matricial polimérico y de difusión que permite liberar el principio activo de manera retardada.The present invention relates to pharmaceutical compositions in the form of tablets for oral administration, which contain active ingredient and pharmaceutically acceptable excipients. The tablets are characterized in that a part of the active substance is released immediately and another part of the active substance is in a polymeric matrix and diffusion system that allows the active substance to be released in a delayed manner.

CO13145004A 2010-12-17 2013-06-18 Pharmaceutical controlled-release tablet for oral administration CO6721021A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2010014153A MX2010014153A (en) 2010-12-17 2010-12-17 Controlled-release pharmaceutical tablet for oral administration.

Publications (1)

Publication Number Publication Date
CO6721021A2 true CO6721021A2 (en) 2013-07-31

Family

ID=46245166

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13145004A CO6721021A2 (en) 2010-12-17 2013-06-18 Pharmaceutical controlled-release tablet for oral administration

Country Status (11)

Country Link
BR (1) BR112013014963A2 (en)
CL (1) CL2013001707A1 (en)
CO (1) CO6721021A2 (en)
CR (1) CR20130288A (en)
DO (1) DOP2013000136A (en)
EC (1) ECSP13012766A (en)
GT (1) GT201300154A (en)
MX (1) MX2010014153A (en)
PE (1) PE20140675A1 (en)
RU (1) RU2603469C2 (en)
WO (1) WO2012080984A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016058813A1 (en) 2014-10-16 2016-04-21 Koninklijke Philips N.V. Aligning a patient within an mr scanner

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL119627A (en) * 1996-11-17 2002-03-10 Yissum Res Dev Co PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT
US20030104052A1 (en) * 2001-10-25 2003-06-05 Bret Berner Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US6723340B2 (en) * 2001-10-25 2004-04-20 Depomed, Inc. Optimal polymer mixtures for gastric retentive tablets
BR0215262A (en) * 2001-12-20 2004-12-28 Pharmacia Corp Zero-order sustained release dosage forms and manufacturing process

Also Published As

Publication number Publication date
PE20140675A1 (en) 2014-06-25
BR112013014963A2 (en) 2016-09-13
MX2010014153A (en) 2012-06-18
DOP2013000136A (en) 2013-10-15
RU2013127408A (en) 2015-01-27
RU2603469C2 (en) 2016-11-27
CR20130288A (en) 2013-08-13
WO2012080984A2 (en) 2012-06-21
GT201300154A (en) 2014-05-07
ECSP13012766A (en) 2013-09-30
WO2012080984A3 (en) 2012-08-16
CL2013001707A1 (en) 2014-01-10

Similar Documents

Publication Publication Date Title
CL2013000424A1 (en) Break-resistant pharmaceutical dosage form comprising a) a pharmacologically active ingredient, b) a polymer, c) a polyalkylene oxide, where a) is present in a controlled release matrix comprising b) and c).
CR11709A (en) SOLID PREPARATION OF ORAL DISINTEGRATION
EA201400172A1 (en) SUSTAINABLE TO DESTRUCTION TABLET THAT PROVIDES IMMEDIATE RELEASE OF MEDICINES
EA201200937A1 (en) SOLID MEDICINE FORM TICAGRELOR
JP2015523407A5 (en)
CL2013003161A1 (en) Pharmaceutical composition in the form of rapidly dissolving microgranules for vaginal administration comprising a) a vaginally active drug, b) a polymeric excipient, c) a sugar alcohol, saccharide or a mixture thereof; preparation procedure
CO6640305A2 (en) Preparation of granules without active ingredients and tablets comprising them
PH12014501408A1 (en) Immediate release multi unit pellet system
CR20110704A (en) COMPOSITIONS OF FIXED DOSAGE SOLID PHARMACEUTICALS THAT INCLUDE IRBESARTAN AND AMYLODIPINE, ITS PREPARATION AND THERAPEUTIC APPLICATION
CO6311067A2 (en) PREPARATION OF TABLETS WITH DELAYED RELEASE CONTAINING POLYVINROL PIRROLIDONAS AND ACTIVE PRINCIPLE
TN2015000135A1 (en) Modified release formulations for oprozomib
PE20131035A1 (en) NEVIRAPIN FORMULATION OF PROLONGED RELEASE
EA201501164A1 (en) SOLID PHARMACEUTICAL MEDICINE FORM
EA201291104A1 (en) ORAL MEDICINAL FORMS BENDAMUSTIN
AR080256A1 (en) SOLID PHARMACEUTICAL FORMULATIONS OF RAMIPRIL AND AMLODIPINO BESYLATE AND ITS PREPARATION
MX2017005163A (en) Onapristone extended-release compositions and methods.
CO6721021A2 (en) Pharmaceutical controlled-release tablet for oral administration
TR201803451T4 (en) OLMESARTAN FORMULATIONS.
BR112012020415A2 (en) pharmaceutical composition for the prevention or treatment of osteoarthritis
UY35324A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DEXKETOPROPHENE AND TRAMADOL
WO2013054178A8 (en) Extended release pharmaceutical compositions containing carmabazepine
UA97982U (en) DRESSING MEDICINE FOR TABLETS
CU20130165A7 (en) MODIFIED RELEASE OF 4-METHYL-3 - [[- 4- (3- PIRIDINIL) -2-PYRIMIDINYL] AMINO] -N-5- (4- METHYL-1H-IMIDAZOL-1- IL) -3- (TRIFLUOROMETIL) FENIL] SOLUBILIZED BENZAMIDE USING ORGANIC ACIDS
EA201992463A1 (en) DRUG DELIVERY SYSTEM
PL400338A1 (en) Solid oral dosage form comprising sunitinib L-malate